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Does renal parenchymal thickness affect bleeding in percutaneous nephrolithotomy?
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Aim: Blood loss is a major concern during percutaneous nephrolithotomy. The aim of this study was to evaluate the effect of access point
parenchymal thickness on bleeding in percutaneous nephrolithotomy procedures.
Materials and methods: In this study 85 patients who had undergone a percutaneous nephrolithotomy operation between February 2009
and July 2011 were reviewed retrospectively. All characteristics of the patients were investigated. The details of the operative procedure
and the renal parenchymal thickness at the puncture site were also recorded. Blood loss was calculated during the peroperative and
postoperative periods. Correlation and multivariate regression analysis were done to detect predictive factors on bleeding.
Results: Of the 85 percutaneous nephrolithotomy procedures done, 12 (14.1%) patients had no diminution of hemoglobin value
postoperatively and were excluded. This left 73 percutaneous nephrolithotomy procedures that were evaluated. The mean peroperative
hemoglobin drop was 1.79 ± 1.17 mg/dL. Stone size, operation time, and grade of hydronephrosis were correlated with hemoglobin drop
significantly (P = 0.047, P = 0.016, and P = 0.034, respectively). There was no correlation between parenchymal thickness and bleeding
(P = 0.545). In multivariate regression analysis, only the operation time was found to be a statistically significant independent predictive
factor for peroperative bleeding in percutaneous nephrolithotomy (P = 0.005).
Conclusion: Renal parenchymal thickness and the grade of hydronephrosis do not predict peroperative hemorrhage in percutaneous
nephrolithotomy procedures.
Key words: Percutaneous nephrolithotomy, parenchymal thickness, hemoglobin drop, bleeding

1. Introduction
Percutaneous nephrolithotomy (PNL) is an established
procedure for surgical treatment in patients with large and
complex renal calculi (1). Development of the technology
and increasing experience in the last 2 decades have led to
increased safety and efficacy. Nevertheless, complications
may still occur. Renal hemorrhage is one of the most
dangerous complications of PNL (2–4). Surgical bleeding
is the main cause of blood loss, and as such, the urological
surgeon is responsible for optimizing renal access,
tract dilation, and renal manipulation and minimizing
technical errors. As numerous functional, morphologic,
biochemical, pathologic, nuclear, and radiologic studies
have shown, PNL causes minimal or no renal injury.
However, there is a belief that thick renal parenchyma is
related to much peroperative and postoperative bleeding
* Correspondence: drhuseyin@hotmail.com
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after a PNL procedure; thin renal parenchyma is also
related to less bleeding. In addition, there have been a few
published studies reporting no correlation between renal
parenchymal thicknesses and bleeding during PNL (5,6).
The aim of this study was to identify the risk factors
predicting peroperative and postoperative bleeding and
to present the correlation between renal parenchymal
thickness and bleeding due to the PNL procedure.
2. Material and methods
After informed consent was obtained verbally, 85 patients
who underwent PNL procedures between February 2009
and July 2011 at Osmaniye State Hospital (Osmaniye,
Turkey) were retrospectively reviewed. Preoperative
patient evaluation included history, clinical examination,
serum creatinine level, complete blood count, coagulation
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profile, and liver function tests. Radiological investigations
included excretory urography and noncontrast
computerized tomography (CT) to figure out the
parenchymal thickness, kidney anatomy, stone position,
and size. All procedures were made by same surgeon
(MMR).
Before surgery, urinary tract infections had been
treated with culture-specific antibiotics. Under the effect
of general anesthesia and after placement of a ureteral
catheter, with the patient prone, the skin was punctured
at the posterior axillary line. The supracostal approach
was performed in 2 (3%) patients. Percutaneous renal
access was founded under the biplane or multidirectional
C-arm fluoroscopic guidance through the posterolateral
plane of the kidney. The pelvicaliceal system was entered
at the lower posterior calix in patients with renal pelvis
or lower caliceal stones. Middle or upper calix punctures
were used when stones were present in these calices. The
tract was dilated using coaxial telescopic dilatators; a 30-F
Amplatz sheath was then advanced over the dilators and
placed in the collecting system. All steps in tract dilation
and Amplatz sheath placement were performed under
fluoroscopic control in all patients. Small stones were
removed with forceps and large ones were disintegrated
with pneumatic, ultrasonic, or combined lithotripters.
Except for 9 (11.8%) patients, a 16-F nephrostomy tube was
placed at the end of the procedure. The tube was removed
after 48 h and the patient was discharged home, provided
that there were no complications. All patients were
evaluated with intravenous pyelogram (IVP) and/or spiral
CT after 1 month postoperatively. The PNL was considered
successful when the patient was stone-free or did not need
any further intervention (clinically insignificant residual
stone fragments) (7). Residual stones that were accessible
through the present nephrostomy tracts were managed
by second-look PNL, while extracorporeal shock wave
lithotripsy (ESWL) was used for inaccessible residuals
larger than 4 mm and follow-up was adopted for residuals
smaller than 4 mm. The patients’ stone-free status was
reevaluated after 3 months with noncontrast CT for those
who required ESWL.
All characteristics of patients were investigated, such
as age, sex, previous operation history, preoperative
creatinine and urine levels, renal components (side,
thickest and thinnest parenchymal thickness, and degree
of hydronephrosis), and stones (site, load). Stone burden
was classified as single calix, pelvis, both pelvis and calyx,
or staghorn stones.
The details of the operative procedure (number, site of
percutaneous tracts, lithotripsy method, operation time,
etc.) and the renal parenchymal thickness at the puncher
side were also recorded.

Hemoglobin (Hb) and hematocrit values were analyzed
preoperatively and postoperatively (1 h and 24 h after
operation). Peroperative Hb drop was evaluated by the
preoperative Hb value subtracted from the postoperative
Hb value at 1 h, and also the added units of transfused
blood (1 g/dL per unit, peroperative if necessary).
Postoperative Hb drop was calculated by the 24-h Hb
value subtracted from the postoperative 1-h Hb level and
also the added units of postoperatively transfused blood.
Blood transfusion was required for the fall in hematocrit
values accompanying hemodynamic instability and
patients with severe hematuria, which were those with a
fall in hematocrit, fall in blood pressure, recurrent clot
retention, and/or a requirement for inotropes to maintain
hemodynamic stability.
Exclusion criteria were subjects without diminution of
Hb value peroperatively and/or postoperatively, and that
had no preoperative BT (blood transfusion).
2.1. Radiological evaluation
Hydronephrosis was classified as grade I (mild), II
(moderate), III (severe), or IV (massive) based on IVP
and ultrasound findings, as described by Fernbach et
al (8). All examinations were performed on a Shimadzu
DIN 3064 CT scanner with 8-mm slice thickness. We
measured 3 sections through each kidney: 1 through
the thinnest parenchymal point, 1 through the thickest
parenchymal point, and 1 at the level of the access point
of the renal parenchyma (reported as the average in case
of multiple tracts). The thickness of renal parenchyma
was measured by means of 2 perpendicular axes through
fixed points in each kidney. The parenchymal thickness
and hydronephrosis degree were established and
confirmed by a radiologist. Intraobserver validation of
renal CT parenchymal thickness and ultrasonography
hydronephrosis measurements in PNL patients was made
after 3 months by the same radiologist.
2.2. Statistical analysis
The data were analyzed using SPSS 18 (SPSS Inc.,
Chicago, IL, USA). The parameters affecting Hb drop
were investigated using Spearman/Pearson correlation
and Student’s t-test, where appropriate. A multiple linear
regression model was used to identify independent
predictors of Hb difference.
A progression of univariate followed by multivariate
analyses was applied to 17 variables selected from the
characteristics of patients, renal components, stones, and
the details of the operative procedure in PNL patients with
decreased Hb value to determine those variables most
predictive of bleeding. The models were compared with
respect to their R2 values, sum of squares for the model,
residual, standard error, F statistics, and related P-value.
Receiver operating characteristic (ROC) curves were also
used. The significance level for P-values was assumed to be
less than 0.05.
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3. Results
Of the 85 PNL procedures, 12 (14.1%) patients who
had no diminution of Hb value postoperatively and/
or no preoperative BT were excluded. Blood transfusion
was needed in 22 of 85 patients (18.7%); 1 patient was
peroperatively, 19 were postoperatively, and 2 were both
peroperatively and postoperatively transfused. In total,
73 PNL procedures were evaluated. Horseshoe kidney
in 1 patient, rotation renal abnormality in 1 patient, and
duplicated caliceal system in 1 patient were observed as
renal anomalies. Sample size was adequate for power size
(80%) and alpha (0.05) according to the power analysis

(n = 73). The mean age of the patients was 48.16 ± 11.3
years, with 50 (68.5%) males and 23 (31.5%) females in the
study. A total of 5 patients experienced perioperative severe
bleeding due to progressive track dilatation, while 1 patient
experienced severe hematuria after hospital discharge due to
an arteriovenous fistula. All bleedings were conservatively
controlled with hemostatic medications; no embolization
was needed. The mean operation time, operation data, stone
size, parenchymal thicknesses, and patients’ characteristics
are presented in Table 1. The mean peroperative Hb drop was
1.79 ± 1.17 mg/dL (range: 0–6.8). The mean postoperative
Hb drop was 0.98 ± 0.72 mg/dL (range: 0–3.8).

Table 1. Patients’ characteristics and operation data.
Patients’ characteristics (N = 73)
Age (years)

Minimum

Maximum

Mean

Standard deviation

20

73

48.16

11.307

Hb loss (mg/dL), peroperative

0

6.8

1.79

1.17

Hb loss (mg/dL), postoperative

0

3.8

0.98

0.72

Stone size (mm)

22

65

39.38

10.636

Operation time (min)

56

250

108.15

40.951

Maximum parenchymal thickness (mm)

9

38

14.06

5.288

Minimum parenchymal thickness (mm)

1

12

6.18

2.724

1
0.52

23

8.63

4.290

1.87

0.85

0.23

Parenchymal thickness of access point (mm)
Preoperative creatinine (mg/dL)

N (%)
Sex
Previous operation (same kidney open, PNL, ESWL)
Side
Access location
Stone location

Male

Female

50 (68.5)

23 (31.5)

Yes

No

22 (30.1)

51 (69.9)

Right

Left

37 (50.7)

36 (49.3)

Lower

Upper

Middle

Multiple

52 (71)
Calix

1 (3)

12 (15)

8 (11)

Pelvis

Calix + pelvis

Multicalix + pelvis

17 (23)

23 (32)

16 (22)

III

IV
23 (31.5)

17 (23)
Access
Nephrostomy
Residual stone
Hydronephrosis (grade)
Lithotripsy

Single

Double

62 (84.9)

11 (15.1)

Tube

Tubeless

64 (88.2)

9 (11.8)

Yes

No

25 (34.2)

48 (65.8)

I

II

10 (13.7)

12 (16.4)

28 (38.4)

Pneumatic

Ultrasonic

Combination

52 (71.2)

16 (21.9)

5 (6.8)

Hb = hemoglobin, PNL = percutaneous nephrolithotomy, ESWL = extracorporeal shock wave lithotripsy.
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In the regression model, factors considered to predict
bleeding were not statistically significant for postoperative
Hb drop. In Table 2, 3 factors (stone size, operation
time, and grade of hydronephrosis) were correlated with
peroperative bleeding significantly (P = 0.047, P = 0.016,
and P = 0.034, respectively). Parenchymal thickness was
not found to be correlated with peroperative bleeding (P
= 0.545).
According to multivariate analysis in Table 3, all
parameters were included in the regression model for
detecting predictive factors related to peroperative
bleeding. Only the operation time was found to be a
statistically significant independent predictive factor
associated with peroperative bleeding (P = 0.005). All other
factors were not found as predictive factors associated
with peroperative bleeding. There was no statistically
significant relationship between postoperative bleeding
and parenchymal thickness of the access point (P = 0.647).
In ROC curve analysis, the cut-off point of operating
time for blood transfusion need was found to be 90 min,
which had a sensitivity of 90% and specificity of 47% (area
under the curve [AUC] = 0.718; P = 0.001; Figure 1).
4. Discussion
Open surgery was the standard therapy for urinary calculi
up to about 30 years ago. However, the development
of minimally invasive treatment methods, such as
ESWL, and simultaneous endourological procedures
like ureterorenoscopy and PNL has replaced open stone

surgery almost completely. It is well recognized that in
the western world, a percutaneous approach is preferred
to open surgery for most cases of complex renal calculi
resistant to ESWL. PNL is a safe and reliable technique for
renal stones. It has replaced open surgery as the treatment
of choice for large, multiple, and staghorn renal calculi
(1,9).
However, it is an invasive procedure with reported
complication rates of 3% to 18% according to different
investigators (2–4). One of the most serious complications
is renal hemorrhage. Blood loss is a normal feature of PNL
because some bleeding may occur during renal puncture,
tract dilation, use of nephroscopy between calices, and
stone disintegration. It is considered a complication only
when a blood transfusion is required. A transfusion
rate of 3% to 23% has been reported. Fortunately, in
most cases bleeding can be controlled with conservative
measures, such as clamping the nephrostomy, hydration
and diuretics, hemostatic medications, and Kaye balloon
tamponade (10,11). Therefore, the necessity of renal
embolization to control severe bleeding is low (range: 0.3%
to 1.4%) (2–4,12–18). The transfusion rate in our series was
comparable to these ranges (18.7%), and no embolization
was needed in our patients with severe bleeding.
In a study by the Clinical Research Office of the
Endourological Society (CROES), the overall complication
rate in PNL was 15%, which commonly involved bleeding.
The predictive factors of bleeding in PNL were operating
time, stone load, caseload, and sheath size (19–21). In

Table 2. Correlation table between hemoglobin drop and operation time, stone size, and hydronephrosis.

Hb drop

Stone size

Operation time

Hydronephrosis

Correlation

Hb drop

Stone size

Operation time

Hydronephrosis

Parenchymal thickness
(for access point)

1

–0.234*

–0.281*

–0.255*

0.073

0.047

0.016

0.034

0.545

1

0.508**

0.334**

–0.195

0.0001

0.005

0.103

1

0.362**

0.001

0.002

0.996

1

–0.047

P
Correlation
P
Correlation
P
Correlation
P

Parenchymal thickness Correlation
(for access point)
P

–0.234*
0.047
–0.281*

0.508**

0.016

0.0001

–0.255*

0.334**

0.362**

0.034

0.005

0.002

0.073

–0.195

0.001

–0.047

0.545

0.103

0.996

0.701

0.701
1

Hb = hemoglobin.
*: Correlation is significant at the 0.05 level, **: correlation is significant at the 0.01 level.
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Table 3. Multivariate analysis of predictive factors for bleeding during PNL. Significance of ANOVAs for regression model was 0.005
(P-value). R = 0.331, R2 = 0.11.
Unstandardized
coefficients B

Factor
Constant

–0.747

Operation time

–0.009

Stone size

Beta

95% Confidence
interval for B

P-value
0.06

–1.527

0.033

–0.331

0.005

–0.016

–0.003

–0.006

–0.055

0.779

-0.048

0.036

Hydronephrosis

–0.161

–0.138

0.357

–0.509

0.187

Stone type (staghorn-other)

–0.228

–0.086

0.63

–1.173

0.717

Age

0.024

0.234

0.128

–0.007

0.056

Sex

–0.121

–0.047

0.773

–0.958

0.716

Operation history

–0.077

–0.188

0.18

–0.192

0.037

Stone location

0.036

0.035

0.202

–0.325

0.397

Tract (single-multiple)

0.448

0.147

0.321

–0.450

1.345

Tubeless

–0.385

–0.098

0.477

–1.464

0.694

Lithotripsy method

0.015

0.008

0.062

–0.480

0.510

Parenchymal thickness (for access
point)

–0.011

–0.038

0.869

–0.143

0.121

Maximal parenchymal thickness

–0.08

–0.035

0.848

–0.079

0.095

Minimum parenchymal thickness

–0.01

–0.021

0.903

–0.169

0.149

Access location

–0.324

–0.284

0.763

–0.683

0.035

Site

–0.89

-–0.037

0.792

–0.754

0.557

Preoperative creatinine level

–1.04

–0.186

0.151

–2.473

0.391

ROC curve

1.0

Sensitivity

0.8
0.6
0.4
0.2
0.0

0.0

0.2

0.4
0.6
1-Specificity

0.8

1.0

Figure 1. ROC curve for operation time and blood transfusion.
Cut-off point was found as 90 min for sensitivity of 90% and
specificity of 47% (AUC = 0.718; P = 0.001).
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our study, multivariate analysis showed that the only
predictive factor of bleeding was operation time (P =
0.001; Figure 2; Table 3). However, caseload was not
studied, all procedures were done by same surgeon, and
also the same sheath size (16 F) was used. In the CROES
study, patients whose operations lasted longer than 75
min (76–115 min) had statistically significantly more
severe postoperative complications compared with those
whose operative time was shorter than 50 min. The risk
of more severe postoperative complications increased even
further for those whose operative time was more than 115
min (20). In another study, Akman et al. found a cut-off
point for blood transfusion as 58 min. The demonstrated
predictive factors for bleeding were the number of access
points, stone type (staghorn or other), diabetes mellitus,
preoperative Hb level, and operation time of up to 58 min
in their study (22). In the present study, if the operation

RİFAİOĞLU et al. / Turk J Med Sci

Hemoglobin Drop (mg/dL)

–2.00

–4.00

–6.00

50

100

150
200
Operation time (min)

250

Figure 2. Scatter-dot figure between hemoglobin drop and
operation time. Fit line with 95% confidence interval.

time was longer than 90 min according to the ROC
analysis, transfusion requirement and also bleeding risk
would be increased (odds ratio = 8.03, relative risk = 5.2;
Figure 1).
Stone size and stone type were detected as predictive
factors for blood transfusion and mean Hb drop in
published studies (22,23). In staghorn calculi, the number
of maneuvers was increased due to reaching renal calices
for stone disintegration and removal. These maneuvers
may cause injury to the renal collecting system and
parenchyma, leading to possible bleeding. In our study,
we demonstrated that there was correlation between
stone size, operation time, and Hb drop. The correlation
coefficient between operation time and Hb drop was higher
than that between stone size and Hb drop (r = –0.281 vs.
r = –0.234, respectively; Table 2). The P-value associated
with correlation was more significant between operation
time and Hb drop than between stone size and Hb drop
(P = 0.016 vs. P = 0.047, respectively). It seems that stone
size could affect Hb drop indirectly via affecting operation
time. On the other hand, in multivariate analysis, which
included stone size, only operation time was found to be an
independent predictive factor for peroperative bleeding.
Akman et al. demonstrated that the grade of
hydronephrosis was not a risk factor for total blood
loss in 649 PNL procedures (22). They also found that
postoperative blood transfusion need was not dependent
on the grade of hydronephrosis. Ahmed et al. evaluated
excessive bleeding after PNL operation (23) and found
that there was no significant difference between the rate
of severe vascular injuries in patients with or without

hydronephrosis. Akman et al. further showed that
presence of hydronephrosis and renal stone size and type
significantly affected the operative time during PNL (22).
In the present study, we demonstrated that the grade of
hydronephrosis did not affect bleeding in regression
analysis, despite the fact that there was a correlation
between Hb drop and the grade of hydronephrosis (Tables
2 and 3; Figure 3). Thus, hydronephrosis did not seem
to affect bleeding directly. Hydronephrosis may affect
bleeding indirectly due to patients’ severe stone load,
which causes prolonged operation time.
Increased number of access points was important in
respect to bleeding. Muslumanoglu et al. reported that an
increased number of access points caused more bleeding
in their study, which included 275 patients. Bleeding
was encountered in 7.6% of patients managed with 1
percutaneous access point, and in 18.5% of cases managed
with 2 or more access points (P < 0.05). In addition to
this, the location of the access point was found as another
risk factor for bleeding in their study. Bleeding was found
in 39.1% and 7.5% of patients managed with supracostal
access and subcostal access, respectively (P < 0.01).
Puncture to upper calices can cause injury of posterior
segmental artery braches, leading to increased risk of
bleeding (24). Akman et al. reported similar results; the
number of access points was detected as an independent
predictive factor for bleeding in multivariate analysis.
Contrarily, they found that the access point was not a risk
factor for bleeding in univariate analysis (22). In some
series, the number of access points was not found to be a risk
factor for vascular injury (13,17,25). In the present study,
neither access point nor access location was detected to be
0.00

Hemoglobin drop (mg/dL)

R2 Linear = 0.079

0.00

-1.00

-2.00

-3.00

-4.00
1

3
2
Grade of hydronephrosis

4

Figure 3. Box-plot graphic between grade of hydronephrosis and
bleeding.
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Hemoglobin drop (mg/dL)

0.00

–2.00

R2 Linear = 0.0005
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having a solitary kidney was detected as a risk factor for
severe bleeding in PNL. In a solitary kidney, compensatory
hypertrophy is a normal physiological response. As a result,
thickening of the renal parenchyma increases kidney size
(23). Another study reported that an ipsilateral renal unit
did not have any effect on the blood loss, but parenchymal
thickness was a significant predictor for bleeding (5). In
contrast, they found P-values of the effect of parenchymal
thickness in bleeding to be 0.05, and they reported that
it was statistically significant but should be insignificant.
Turna et al. evaluated the factors affecting blood loss in
PNL. Their regression model included renal parenchymal
thickness, for which the size categories were 10 mm in
diameter or smaller and larger than 10 mm. They found
that parenchymal thickness did not affect bleeding in
PNL (6). According to our study, parenchymal thickness
of the access point was measured and found statistically
insignificant for blood loss in multivariate analyses, which
include parenchymal thickness as a continuous variable
(Tables 2 and 3; Figure 4).
As a conclusion, only the operation time affects mean
blood loss in PNL. All other parameters, such as age, sex,
previous treatment, maximum or minimum parenchymal
thickness, parenchymal thickness of access point, side,
access location, stone location, stone size, number of
access points, nephrostomy, and type of lithotripsy, did
not affect bleeding.
According to the present study, renal parenchymal
thickness and the grade of hydronephrosis did not predict
peroperative hemorrhage in PNL procedures. Thin renal
parenchyma was not associated with less bleeding, and
thick renal parenchyma was not associated with greater
bleeding.
R2 Linear = 0.0005

a risk factor for blood loss according to the multivariate
analysis. Since we had only 2 patients managed by upper
pole access, a limitation of the present study, we did not
have an adequate number of patients with upper pole
access. In addition, this study was designed to evaluate the
relationship between parenchymal thickness and bleeding
with an adequate number of patients according to the
statistical power size. It was difficult to say that upper pole
puncture had an effect on bleeding with only 2 patients.
In a retrospective clinical study including 74
patients who had undergone PNL, Cho et al. evaluated
the lithotripsy method. They compared the safety and
efficacy of the lithotripsy method in the 74 patients; 35
underwent PNL treated with pneumatic lithotripsy and 39
underwent PNL treated with combined (pneumatic and
ultrasonic) lithotripsy. They demonstrated that blood loss
in the combined group was significantly lower than in the
pneumatic group (1.12 ± 0.61 vs. 1.39 ± 1.02, P = 0.013).
However, Cho et al. used Student’s t-test instead of the
multivariate test (26). Pneumatic lithotripsy works with a
ballistic effect on the stone, and these effects could reflect
on renal pelvis via the stone. Ballistic trauma could cause
bleeding in the renal pelvis. The same scenario could be
possible in ultrasonic lithotripsy in terms of microtrauma.
It is known that many factors could affect blood loss in
a PNL operation other than the lithotripsy method.
Additionally, Lehman et al. randomized 30 patients who
underwent PNL with ultrasonic lithotripsy alone and a
combination of pneumatic and ultrasonic lithotripsy. They
reported no differences in mean blood loss between the
groups (27). In a recent study, we found that the lithotripsy
technique was not a predictive factor for bleeding in
multivariate analysis.
Severe hydronephrosis usually causes parenchymal
thickness over a long-term period and deteriorates renal
function due to chronic obstruction. We detected no
correlation between the grade of hydronephrosis and
maximum, minimum, mean, and access point parenchymal
thickness (r = –0.144, P = 0.2; r = –0.129, P = 0.2; r = 0.193,
P = 0.1; and r = –0.47, P = 0.7, respectively). According to
our results, parenchymal thickness of the access point was
not found to be an independent predictive factor for blood
loss during operation in multivariate analysis (Table 3).
Thick renal parenchyma did not bleed much more than thin
renal parenchyma. In the literature, it was speculated that
puncture and dilatation through thick renal parenchyma
might increase the possibility of bleeding due to damage
of more renal tissue and its vascular supply. El-Nahas et
al. reported that increased parenchymal thickness due to
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Figure 4. Scatter-dot graphic between parenchymal thickness of
access point and bleeding. Fit line with 95% confidence interval.
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